The "Viral Vector Vaccines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Viral Vector Vaccines was estimated at US$773.4 Million in ...
Researchers from Purdue University and the U.S. Centers for Disease Control and Prevention have recently developed a novel influenza vaccine candidate that uses a bovine adenoviral (BAd) vector to ...
Peer-Reviewed Article Describes Clinical and Immunologic Rationale for Dual-Antigen MVA-Based Vaccine Designed to Address Limitations of First-Generation COVID-19 Vaccines in Highly Vulnerable ...
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Mvabea Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering. The Mvabea ...
A groundbreaking study explains why certain COVID-19 vaccines caused dangerous blood clots, hemorrhages and VITT syndrome, resulting in the deaths of around 200 people in Europe.
Suresh Mittal, Distinguished Professor of Virology in the College of Veterinary Medicine, presented “Universal Influenza Vaccine — An Aspiration or Reality?” at the Westwood Lecture Series on Jan. 28.
Live attenuated vaccines mimic natural infections, providing strong immunity but require refrigeration and caution for immunocompromised individuals. Subunit vaccines offer targeted immunity without ...
This letter to the editor presents an in-depth overview of the current state of Nipah virus (NiV) vaccine development, highlighting both scientific advancements and critical challenges that still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results